4
Changes in Ownership
Axogen, Inc. Filed Acc 0000805928-22-000034
Chief R&D Officer gave up 2,770 shares (to pay taxes)
- Chief R&D Officer acquired 11,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Scopelianos Angelo · Chief R&D Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2022-03-16 | Exercise or conversion : show line 1 in the form | +11,000 | 22,950 | D | ||
| 2022-03-16 | Shares withheld for taxes : show line 2 in the form | −2,770 | $7.97 | $22,077 | 20,180 | D |
Table II: Derivative
3 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-03-16 | Exercise or conversion : show line 3 in the form Restricted Stock Units | −11,000 | 11,000 | D |
| 2022-03-16 | Grant or award : show line 4 in the form Restricted Stock Units | +42,563 | 42,563 | D |
| 2022-03-16 | Grant or award : show line 5 in the form Employee Stock Option (right to purchase) | +39,700 | 39,700 | D |
Loading xslF345X03/wf-form4_164763424502227.xml…